Multiple Sclerosis Treatment Experience Questionnaire (MSTEQ)



Similar documents
Information about medicines for multiple sclerosis

Information About Medicines for Multiple Sclerosis

Which injectable medication should I take for relapsing-remitting multiple sclerosis?

Disease Modifying Therapies for MS

Disease Modifying Therapies for MS

Medication Guide Rebif (Re-bif) Interferon beta-1a (in-ter-feer-on beta-one-â)

MEDICATION GUIDE REBIF interferon beta-1a Injection for subcutaneous use

Medication Guide Rebif (Re-bif) Interferon beta-1a (in-ter-feer-on beta-one-â)

The MS Disease- Modifying Drugs. Gener al information

DISEASE MODIFYING THERAPY CARE PATHWAY. Multiple Sclerosis Service

Study Support Materials Cover Sheet

Interferons (Avonex, Betaferon, Rebif ) for relapsing remitting multiple sclerosis (RRMS)

Interferons (Avonex, Betaferon, Rebif ) for primary progressive multiple sclerosis (RRMS)

Bayer Receives FDA Approval for BETACONNECT First and Only Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis (RRMS) Treatment

Multiple sclerosis disease-modifying drugs second line treatments

Understandi your multipl sclerosis medications URAC. All Walgreens specialty pharmacy locations are ACHC and URAC accredited.

Interferons (Avonex, Betaferon, Rebif ) for secondary progressive multiple sclerosis (SPMS)

Treatments for MS: Immunotherapy. Gilenya (fingolimod) Glatiramer acetate (Copaxone )

MOTOR VEHICLE ACCIDENT QUESTIONNAIRE

Multiple Sclerosis: What You Need To Know. For Professionals

National Multiple Sclerosis Society. Disease Modification in Multiple Sclerosis. Current as of January 2, 2013

Heart problems - What are the possible side effects of AVONEX? What is AVONEX? Who should not take AVONEX?

Patient Group Input to CADTH

Spinal Injections. North American Spine Society Public Education Series

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Disease modifying drug therapy

Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)

Resources for the Primary Care Provider. Please print these out for reference

Betaferon (interferon beta 1b)

Medication Policy Manual. Topic: Plegridy, peginterferon beta-1a Date of Origin: December 12, 2014

St. Luke s MS Center New Patient Questionnaire. Name: Date: Birth date: Right or Left handed? Who is your Primary Doctor?

The MS Disease- Modifying Medications GENERAL INFORMATION

Medication Guide BETASERON (bay-ta-seer-on)

Multiple Sclerosis. Causes and Risks: Signs and Symptoms:

MEDICATION GUIDE (ex tā vee uh) What is the most important information I should know about EXTAVIA?

The MS Disease- Modifying Medications

A blood sample will be collected annually for up to 2 years for JCV antibody testing.

Progress in MS: Current and Emerging Therapies

A neurologist would assess your eligibility and suitability for the DMTs.

MDwise Right Choices Program

Relapsing-remitting multiple sclerosis Ambulatory with or without aid

SECTION 2. Section 2 Multiple Sclerosis (MS) Drug Coverage

Medications for chronic pain

For the Patient: Paclitaxel injection Other names: TAXOL

Emergency Care for Patients of The James

SOUTH TAMPA MULTIPLE SCLEROSIS CENTER

MEDICATION GUIDE SYLATRON (SY-LA-TRON) (Peginterferon alfa-2b)

The MS Disease- Modifying Medications

New treatments in MS What s here and what s nearly here

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Medication Policy Manual. Topic: Gilenya, fingolimod Date of Origin: November 22, 2010

For the Patient: Dasatinib Other names: SPRYCEL

Multiple Sclerosis (MS) is a disease of the central nervous system (including the brain and spinal cord) in which the nerves degenerate.

Disease modifying drug therapy. what you need to know

PAIN MANAGEMENT During Your Hospital Stay

NHS BOURNEMOUTH AND POOLE AND NHS DORSET

EMD Serono Presents New Data on Rebif (Interferon beta-1a) and Multiple Sclerosis Pipeline at Joint ACTRIMS-ECTRIMS Meeting in Boston

For the Patient: GDP Other names: LYGDP

Chemotherapy What It Is, How It Helps

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and Clotrimazole 1% w/w

Multiple Sclerosis Update. Bridget A. Bagert, MD, MPH Director, Ochsner Multiple Sclerosis Center

MEDICATION GUIDE mitoxantrone (mito-xan-trone) for injection concentrate

Cancer-Related Pain. A Guide for Patients and Caregivers

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Resources for the Patient. Please print these out and give them to your patients with MS

MOHS MICROGRAPHIC SURGERY

MS Treatments Gilenya

Medication Policy Manual. Topic: Betaseron, Extavia, interferon beta-1b Date of Origin: June 18, 2004

Humulin (HU-mu-lin) R

Carla Duff, CPNP MSN CCRP Clinical Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and

SOUTH TAMPA MULTIPLE SCLEROSIS CENTER PATIENT/ CARE GIVER QUESTIONNAIRE

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Now that your Doctor has prescribed Livial for you

Disease modifying drug therapy

A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market

Insect and Animal Allergens. Stinging Insect Allergy. A Patient s Guide

Disease modifying therapies (DMTs) for MS

Disease modifying therapies (DMTs) for MS

Version History. Previous Versions. Policy Title. Drugs for MS.Drug facts box Glatiramer Acetate Version 1.0 Author

Current and future options of MS treatment Prof. Dr. Karl Vass, AKH Wien

Multiple Sclerosis (MS) Aprile Royal, Novartis Pharma Canada Inc. September 21, 2011 Toronto, ON

Home Health & Hospice. Managing Your Pain

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

How to S.E.A.R.C.H. SM for the Right MS Therapy For You!

Medicines for Psoriatic Arthritis. A Review of the Research for Adults

Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C

Appendix 2 Questions included in patients questionnaire. 1. What type of treatment do you use for your MS? Please choose one of the following options:

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

MEDICATION GUIDE STELARA

PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to Multiple

MS Disease Management Program

How to Care for Yourself after Lumbar Posterior Decompression

Integrating New Treatments: A Case Based Approach

Patient Guide. Important information for patients starting therapy with LEMTRADA (alemtuzumab)

Can an administrative drug claims database be used to understand claimant drug utilization?

Copaxone for multiple sclerosis (RRMS)

MS Essentials. Disease modifying drugs

Living with MS. Multiple Sclerosis Society of Canada Call toll-free in Canada: Web site:

Data include post-hoc assessments of controlled studies in relapsing MS regarding evolution of

what is warfarin? Treatment with Warfarin (Coumadin ) What is warfarin?

Transcription:

Multiple Sclerosis Treatment Experience Questionnaire (MSTEQ) Name: Today s date (mm/dd/yy): It is important that you take your as prescribed by your physician. However, from to you may find it difficult or impossible to take your DMT as prescribed. This instrument is designed to help you and your physician understand what these barriers are and to come up with ways to make it easier to take your treatment. It is very important that you are honest when completing this instrument so that your MS team can help to look after you better.. ) Which of the following are you currently taking to treat Multiple Sclerosis (MS)? (Check one) Copaxone (Glatiramer Acetate) Avonex or Avonex pre- filled syringe (Interferon Beta a - intramuscular) Rebif (Interferon Beta a - subcutaneous) Betaseron or Betaferon (Interferon Beta b - subcutaneous) Tysabri (Natalizumab) Novantrone (Mitoxantrone) Other, please specify:.) On how many days during the last weeks (8 days) were you supposed to take this? (Check one) Every day (8 s) Every other day ( s) Three s a week ( s) Once a week ( s) Once a month ( ) Other, please specify:

.) During the past weeks (8 days) did you manually inject, use an auto- injection device, or do both? (Check one) Manual injection only Auto injection only Both manual and auto- injection Not applicable / I take a pill.) During the past weeks (8 days), how often was your injection done by someone else? (Check one) Never A few s About half the Most of the All or nearly all of the.) Did you miss or forget to take any doses of this during the last weeks (8 days)? (Check one) Yes No.) How many doses did you miss or forget? (Complete blank) IF YOU HAVEN T SKIPPED ANY DOSES IN THE PAST 8 DAYS, SKIP TO QUESTION 7

(Complete this section only if you missed a dose in the past 8 days) 6. How important were the following factors in missing or forgetting to take a dose? (Please check one answer for each) Not important A little Moderately Extremely at all important important important Memory problems Too busy Side effects of injection Side effects of Fear of needles Needing someone to help me take my Ran out of or could not refill my prescription Away from home and could not access my Feeling anxious, depressed, or nervous about taking my Dissatisfaction with my Did not want taking my to interfere with activities Tired of taking my Did not feel like taking my For completion by examiner only; DMT- Barr Score:

7. During the past weeks (8 days) did you (Please check one answer for each) Never A few s About half the Most of the All or nearly all the Have bleeding at the injection site? Have pain, stinging, burning, or soreness at the injection site during Have itching or irritation at the injection site during administration of Feel nervous or anxious during Have pain, stinging, burning, or soreness at the injection site after Have itching or irritation at the injection site after administration of Have swelling, welts, or lumps at the injection site after administration of Have abnormal redness of the skin or a rash at the injection site after Have bruises at the injection site after Have chills, headaches, or flu- like symptoms after For completion by examiner only; DMT- SE Score:

8. During the past weeks (8 days) did you usually (Please check one answer for each) No Yes Use ice, a cold pack or a cold compress on the injection site prior to taking Use heat, a heat pack, or a hot compress on the injection site prior to taking Take oral s for pain relief, such as Aleve, Ibuprofen, Tylenol, aspirin, prior to taking your treatment? Use a cream, ointment, or lotion at the injection site for pain relief when you took Take an anti- histamine to help control rashes or swelling when you took Use a cream, ointment, or lotion at the injection site for relief from itching when you took Massage the injection site after your treatment to relieve swelling, itching or other discomfort? For completion by examiner only; DMT- COPE Score: 9.) Overall, how hard or easy do you feel it is to take your current Multiple Sclerosis treatment as recommended by your physician? (Check one) Extremely easy A little hard Moderately hard Very hard Extremely hard 0.) Overall, how satisfied are you with how things have been with your treatment during the past weeks (8 days)? (Check one) Not satisfied at all A little satisfied Moderately satisfied Very satisfied Completely satisfied Thank you for completing this survey, you are now finished. Please check over your answers carefully, then return the completed form to the examiner.